2023 / 02

Next Paper
DOI: 10.47183/mes.2023.012

ORIGINAL RESEARCH

Mini-invasive transmitral myectomy and mitral valve replacement in obstructive hypertrophic cardiomyopathy case

Zemlyannikov ID1, Tsaregorodtsev AV1, Nguyen HN2, Ferzalieva ZR1, Drozhdina AA1
About authors

1 Pirogov Russian National Research Medical University, Moscow, Russia

2 Bakulev National Medical Research Center of Cardiovascular Surgery, Moscow, Russia

Correspondence should be addressed: Ivan D. Zemlyannikov
Ostrovityanova, 1, Moscow, 117997, Russia; moc.liamg@navivokinnaylmez

About paper

Acknowledgments: the authors thank O.Yu Pidanov for the clinical case.

Author contribution: Zemlyannikov ID, Nguyen HN — literature analysis, text authoring; Tsaregorodtsev AV — clinical case analysis, literature collection and analysis, text authoring; Ferzalieva ZR, Drozhdina AA — text editing.

Compliance with the ethical standards: the patient signed the form of voluntary informed consent for surgical treatment.

Received: 2023-03-05 Accepted: 2023-04-29 Published online: 2023-05-22
|
  1. Maron BJ, Maron MS. Hypertrophic cardiomyopathy. Lancet. 2013; 381 (9862): 242–55.
  2. Cao C, Gupta S, Chandrakumar D, Nienaber TA, Indraratna P, Ang SC, et al. A meta-analysis of minimally invasive versus conventional mitral valve repair for patients with degenerative mitral disease. Ann Cardiothorac Surg. 2013; 2 (6): 693–703.
  3. Torsten Doenst, Mahmoud Diab, Christoph Sponholz, Michael Bauer, Gloria Färber The Opportunities and Limitations of Minimally Invasive Cardiac Surgery. Dtsch Arztebl Int. 2017; 114 (46): 777–84.
  4. Knyshov G, Lazoryshynets V, Rudenko K, Kravchuk B, Beshlyaga V, Zalevsky V, et al. Is surgery the gold standard in the treatment of obstructive hypertrophic cardiomyopathy? Interact Cardiovasc Thorac Surg. 2013; 16 (1): 5–9.
  5. Hikaru Matsuda. Transatrial and Transmitral Myectomy for Hypertrophic Obstructive Cardiomyopathy of the Left Ventricle. Operative techniques in thoracic and cardiovascular surgery. 2004; 9 (4): 304–9.
  6. Sakaguchi T, Totsugawa T, Tamura K, Hiraoka A, Chikazawa G, Yoshitaka H. Minimally invasive trans-mitral septal myectomy for diffuse-type hypertrophic obstructive cardiomyopathy. Gen Thorac Cardiovasc Surg. 2018; 66 (6): 321–6.
  7. Wehman B, Ghoreishi M, Foster N, Wang L, D'Ambra MN, Maassel N, Maghami S, Quinn R, Dawood M, Fisher S, Gammie JS. Transmitral Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy. Ann Thorac Surg. 2018; 105 (4): 1102–8.
  8. Ommen SR, Mital S, Burke MA, et al. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020; 142 (25): e533–e557.
  9. Bogachev-Prokophiev A, Afanasyev A, Zheleznev S, Fomenko M, Sharifulin R, Kretov E et al. Mitral valve repair or replacement in hypertrophic obstructive cardiomyopathy: a prospective randomized study. Interact CardioVasc Thorac Surg. 2017; 25: 356–62.
  10. Afanasyev A, Bogachev-Prokophiev A, Lenko E, Sharifulin R, Ovcharov M, Kozmin D, et al. Myectomy with mitral valve repair versus replacement in adult patients with hypertrophic obstructive cardiomyopathy: a systematic review and meta-analysis. Interact CardioVasc Thorac Surg. 2019; 28: 465–72.